Chronic inflammatory demyelinating polyneuropathy with positive anti-myelin associated glycoprotein antibodies: back to clinical basics

Yusuf A. Rajabally*

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

Abstract

Chronic inflammatory demyelinating polyneuropathy with anti-myelin associated glycoprotein antibodies represents a small subgroup of patients for whom management may not be straightforward. A recent study offers insight into this issue, with results suggesting priority should be given to the clinical phenotype.
Original languageEnglish
Pages (from-to)301-302
JournalEuropean Journal of Neurology
Volume30
Issue number2
Early online date21 Nov 2022
DOIs
Publication statusE-pub ahead of print - 21 Nov 2022

Keywords

  • Neurology (clinical)
  • Neurology

Fingerprint

Dive into the research topics of 'Chronic inflammatory demyelinating polyneuropathy with positive anti-myelin associated glycoprotein antibodies: back to clinical basics'. Together they form a unique fingerprint.

Cite this